V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10453680 | 10034409 | 1.76 | 50.7 | Adjuvant (A) | 2016-03-19 | 2016-04-05 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100905908 |
| 10453692 | 10034410 | 1.8 | 76.2 | Palliative (P) | 2017-08-25 | 2017-09-04 | Capecitabine 5days + RT | 02 | N | CAPECITABINE | 100077363 |
| 10453693 | 10034411 | 1.9 | 58 | Disease modification (D) | 2021-05-11 | 2021-05-18 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101856086 |
| 10453695 | 10034412 | 1.8 | 89.1 | null | 2022-01-20 | 2022-01-20 | CHOP R - 21 days | 02 | null | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100111515 |
| 10453708 | 10034413 | 1.73 | null | Palliative (P) | 2018-09-27 | 2018-10-19 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 100972434 |
| 10453709 | 10034414 | 1.69 | 86.5 | Palliative (P) | 2019-09-28 | 2019-09-28 | Rituximab | 02 | N | RITUXIMAB | 101351556 |
| 10453728 | 10034415 | 1.75 | 94.7 | Adjuvant (A) | 2021-05-12 | 2021-05-12 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 101709645 |
| 10453742 | 10034416 | null | 70.55 | Curative (C) | 2018-12-26 | 2019-01-30 | IBRUTINIB | 2 | N | IBRUTINIB | 100344611 |
| 10453751 | 10034417 | 1.65 | 71.3 | null | 2019-01-14 | 2019-02-14 | IBRUTINIB | 02 | null | IBRUTINIB | 100898958 |
| 10453784 | 10034418 | null | null | Palliative (P) | 2018-04-19 | 2018-04-19 | PEMBROLIZUMAB | N | N | PEMBROLIZUMAB | 100583853 |
| 10453787 | 10034419 | 1.9 | null | 03 | 2018-02-19 | 2018-02-27 | CHOP R - 21 days | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100320740 |
| 10453843 | 10034420 | 1.7 | 81 | Palliative (P) | 2020-10-03 | 2020-10-24 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 101158603 |
| 10453856 | 10034421 | 1.62 | 65.5 | Curative (C) | 2020-04-12 | 2020-04-12 | Docetaxel 75mg/m2 (21 day) | 02 | N | DOCETAXEL | 100830831 |
| 10453932 | 10034422 | 1.65 | 90.6 | Palliative (P) | 2018-01-05 | 2018-01-26 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE | 100489335 |
| 10453939 | 10034423 | 1.76 | 77.7 | Palliative (P) | 2018-07-27 | 2018-07-28 | Rituximab | 02 | N | RITUXIMAB | 101160114 |
| 10453940 | 10034424 | 1.7 | 82.8 | Adjuvant (A) | 2018-09-19 | 2018-09-20 | PEMBROLIZUMAB | 02 | null | RITUXIMAB | 100142124 |
| 10453956 | 10034425 | 1.71 | 80.6 | null | 2022-04-09 | 2022-04-23 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100912252 |
| 10453963 | 10034426 | 1.59 | 96.4 | null | 2022-01-29 | 2022-03-11 | Docetaxel | 02 | null | DOCETAXEL | 100852461 |
| 10453982 | 10034427 | 1.69 | 42 | 03 | 2019-02-28 | 2019-03-18 | Capecitabine + Oxaliplatin 21day | 02 | N | CAPECITABINE | 100544558 |
| 10453993 | 10034428 | 1.6 | 88.6 | Adjuvant (A) | 2019-07-31 | 2019-08-25 | Rituximab | 02 | N | RITUXIMAB | 101183401 |
| 10453995 | 10034429 | 1.69 | 0 | null | 2020-02-27 | 2020-02-27 | CAPECITABINE + OXALIPLATIN | 02 | null | CAPECITABINE + OXALIPLATIN | 100727342 |
| 10454002 | 10034430 | 1.74 | null | Neo-adjuvant (N) | 2017-01-04 | 2017-01-13 | Docetaxel | null | null | DOCETAXEL | 101006275 |
| 10454028 | 10034431 | 1.78 | 90 | Curative (C) | 2019-07-20 | 2019-07-27 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101637406 |
| 10454029 | 10034432 | 1.58 | 71.5 | 03 | 2016-09-02 | 2016-09-09 | Capecitabine 35days + RT | 02 | N | CAPECITABINE | 101221833 |
| 10454041 | 10034433 | 1.85 | 81 | Curative (C) | 2019-03-11 | 2019-03-17 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 101809628 |
| 10454051 | 10034434 | null | 85.5 | Adjuvant (A) | 2019-07-25 | 2019-07-25 | Capecitabine + Oxaliplatin 21day | 02 | N | PEMBROLIZUMAB | 100901255 |
| 10454052 | 10034435 | 1.75 | 69.8 | null | 2021-11-11 | 2021-11-17 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE + OXALIPLATIN | 100356447 |
| 10454097 | 10034436 | 1.58 | 72 | Palliative (P) | 2021-05-12 | 2021-05-12 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100629296 |
| 10454101 | 10034437 | 1.68 | 75.2 | Curative (C) | 2017-10-03 | 2017-10-09 | CHOP R - 21 days | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101142303 |
| 10454116 | 10034438 | 1.66 | 74.25 | Neo-adjuvant (N) | 2015-09-24 | 2015-10-14 | CAPECITABINE + RT | 02 | N | CAPECITABINE | 100181408 |
| 10454118 | 10034439 | 1.75 | 47.7 | null | 2021-03-27 | 2021-04-05 | Capecitabine + Oxaliplatin 21day | 02 | null | CAPECITABINE | 100558515 |
| 10454134 | 10034440 | 1.82 | 81 | Curative (C) | 2019-12-25 | 2020-01-15 | Rituximab | 02 | null | RITUXIMAB | 101354496 |
| 10454143 | 10034441 | null | 76.7 | Curative (C) | 2017-09-25 | 2017-10-27 | IBRUTINIB | 2 | N | IBRUTINIB | 100573566 |
| 10454145 | 10034442 | 1.72 | 58 | null | 2017-08-09 | 2017-08-09 | Capecitabine | 02 | N | CAPECITABINE | 101695739 |
| 10454153 | 10034443 | 1.53 | 80.4 | Palliative (P) | 2016-05-19 | 2016-05-19 | IBRUTINIB | 02 | N | IBRUTINIB | 101392199 |
| 10454155 | 10034444 | null | 77 | null | null | 2016-11-24 | Capecitabine + Oxaliplatin 21day | 02 | N | IBRUTINIB | 101601969 |
| 10454170 | 10034445 | 1.54 | 68.8 | null | 2022-02-19 | 2022-02-26 | IBRUTINIB | null | null | IBRUTINIB | 101851118 |
| 10454171 | 10034446 | 1.55 | 90 | null | null | 2018-01-04 | CAPECITABINE + OXALIPLATIN | 02 | null | DOCETAXEL | 100981638 |
| 10454194 | 10034447 | 1.65 | 62.9 | Palliative (P) | 2018-05-16 | 2018-05-26 | Rituximab | 02 | N | RITUXIMAB | 100060934 |
| 10454205 | 10034448 | 1.73 | 103.6 | Curative (C) | 2019-12-15 | 2019-12-20 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101664936 |
| 10454227 | 10034449 | 1.62 | null | 03 | 2020-01-06 | 2020-01-14 | IBRUTINIB | 02 | N | IBRUTINIB | 100226707 |
| 10454240 | 10034450 | 1.52 | 83.6 | Adjuvant (A) | 2020-01-17 | 2020-01-17 | Capecitabine + Oxaliplatin 21day | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100163585 |
| 10454258 | 10034451 | 1.68 | 54.7 | 03 | 2018-04-03 | 2018-04-03 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100642441 |
| 10454260 | 10034452 | null | null | Adjuvant (A) | 2021-12-19 | 2021-12-25 | CHOP R | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101262536 |
| 10454265 | 10034453 | 1.82 | 53.45 | 03 | 2017-05-26 | 2017-05-27 | PEMBROLIZUMAB | 02 | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 101446436 |
| 10454266 | 10034454 | 1.77 | 65 | Neo-adjuvant (N) | 2019-05-23 | 2019-05-30 | Capecitabine + Oxaliplatin 21day | 02 | null | DOCETAXEL | 100238088 |
| 10454267 | 10034455 | 1.76 | 73 | null | 2021-10-10 | 2021-10-10 | Docetaxel | 02 | null | DOCETAXEL | 100492177 |
| 10454274 | 10034456 | 1.56 | 73.6 | Curative (C) | 2018-06-09 | 2018-06-09 | CHOP R | N | N | CYCLOPHOSPHAMIDE + DOXORUBICIN + RITUXIMAB + VINCRISTINE | 100109969 |
| 10454285 | 10034457 | 1.75 | 94.7 | Curative (C) | 2019-09-14 | 2019-10-04 | CAPECITABINE + OXALIPLATIN | 02 | N | CAPECITABINE + OXALIPLATIN | 101404545 |
| 10454287 | 10034458 | 1.54 | 88 | 03 | 2020-03-08 | 2020-03-08 | IBRUTINIB | 02 | N | IBRUTINIB | 100249366 |